Aurora Cannabis Inc. - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES

Ticker Exchange SIC # Website Latest Ticker
ACB Nasdaq 5122 www.auroramj.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurora Cannabis Inc.

Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond - Sep 16th, 2026 5:05 am
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid - Sep 15th, 2026 11:30 am
Curaleaf Urges Aurora Cannabis Shareholders to Tender Shares to Takeover Offer - Sep 15th, 2026 8:09 am
Curaleaf Sends Letter to Aurora Shareholders - Sep 15th, 2026 5:30 am
Curaleaf Asks Regulators to Freeze Aurora’s Stock Sales as Hostile Bid Drags On - Sep 14th, 2026 1:50 pm
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts - Sep 14th, 2026 12:12 pm
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell? - Sep 11th, 2026 6:44 am
Aurora and Curaleaf Continue Sniping As Hostile Bid Heats Up - Sep 9th, 2026 8:22 am
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business - Sep 9th, 2026 5:05 am
Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora - Sep 8th, 2026 7:33 am
Aurora Cannabis Board Recommends Rejecting Curaleaf Bid - Sep 2nd, 2026 2:14 pm
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders - Sep 2nd, 2026 9:17 am
Aurora Cannabis Urges Shareholders to Reject Curaleaf's Takeover Bid - Sep 2nd, 2026 5:59 am